TradesZ
Top 10 stocks to add now

NVDA vs SMR — which is the better buy? — what our data shows

⚡ TradesZ research ·Updated June 30, 2026 ·~2 min read ·Grounded in SEC data

Both NVDA and SMR are riding big technology waves — one in AI chips, one in small nuclear reactors — but our data paints a different picture for each. Let's break down what the numbers actually say.

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

What our data shows

NVIDIA CORP logo NVDA NVIDIA CORP 🟢Bullish lean
Our data shows no red flags at all for NVIDIA — it looks like a well-established company with nothing alarming hiding in its filings.
NuScale Power Corporation logo SMR NuScale Power Corporation Neutral
NuScale is focused on building small nuclear reactors — a brand new and unproven energy technology — and while our data shows no failure flags, it's still a very early-stage bet on a future that hasn't arrived yet.
Nuclear SMR

The takeaway

Neutral

NVDA comes in clean with no warning signs, while SMR also carries no failure flags but is a much earlier-stage story in an emerging energy space — so it really comes down to how much uncertainty you're comfortable sitting with.

But watch out
Smart-money signals lag the market (13F filings ~45 days) and never guarantee direction — always check the latest price and news yourself.
📈
Before you buy

Before you buy anything —

See the 10 stocks our team is most bullish on right now — under-the-radar names we believe have monster upside potential, in plain English. Free.

Show me the 10 stocks — free →
Free · no credit card · unsubscribe in one click

Have your own question?

Ask in plain English — our data answers. Free for retail readers.

Ask a question →

Informational research, not personalized investment advice.